Moleculin Biotech MBRX
NASDAQ MBRX
$6.31 +0.12 (+1.94%)
At close: Oct 21, 2026 · 4:00 PM EDT

Moleculin Biotech (MBRX) Debt Ratio (2015 - 2017)

Updated

Moleculin Biotech's Debt Ratio came in at 0.01 for Q1 2017, down 99.7% from 2.12 a year earlier and down 70.6% from the prior quarter.

Analysis

Moleculin Biotech (MBRX) Debt Ratio (2015 - 2017) Analysis & Trends

For FY2016, Moleculin Biotech's Debt Ratio was 0.02, down 99.9% from FY2015.

  • Going back by year, Debt Ratio was 16.02 in FY2015.
  • Business Quant data shows MBRX's Debt Ratio at 0.02 (Q4 2016), 0.02 (Q3 2016) and 0.02 (Q2 2016) in the three quarters before Q1 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Moleculin Biotech 35.50 Mn 5.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 0.01
Dec 31, 2016 0.02
Sep 30, 2016 0.02
Jun 30, 2016 0.02
Mar 31, 2016 2.12
Dec 31, 2015 16.02
API Access

Moleculin Biotech Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=MBRX&period=max&api_key=YOUR_API_KEY